IDH1 and anaplastic oligodendroglioma: As detailed in Table 2, overall, 3% (473/14,726) of solid tumour cancer cases harbored mutations in IDH1. The highest frequencies were present in oligodendrogliomas, anaplastic oligodendrogliomas, and diffuse astrocytomas.